Investor4321

AQST PDUFA Approval on the Second

Long
NASDAQ:AQST   Aquestive Therapeutics, Inc.
You guys know I love biotechs with press releases coming up. I also like to wait to enter until the charts look bullish. Aquestive Therapeutics fell from $8 to $4 in September 2020, and I think they could pull back eventually, regardless of press releases. Now that they have an approval coming up on the second, I expect them to perform phenomenally for the rest of February. They may even push all the way back up to $8. I chose to post now because they look very bullish, at the bottom of the RSI and the MACD looks like it may cross soon. Good Luck!

Disclaimer

The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.